Biondvax Pharmaceuticals Ltd - ADR

NASDAQ:BVXV  
1.32
+0.02 (+1.54%)
Earnings Announcements

BiondVax Announces Q4 Results

Published: 03/28/2022 11:31 GMT
Biondvax Pharmaceuticals Ltd - ADR (BVXV) - Biondvax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.